Clinical Trials List
Protocol NumberES-CMSC01-D1101
Active
2022-12-01 - 2028-12-31
Phase I/II
Recruiting1
ICD-10G35
Multiple sclerosis
ICD-9340
Multiple sclerosis
-
Trial Applicant
EVER SUPREME BIO TECHNOLOGY CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ching-Hua Lu Lu Division of Neurology
- 邵儀菁 Division of Ophthalmology
- 張育嘉 Division of Neurology
- Chon-Haw Tsai Division of Neurology
- Wen-Chien Cheng Division of Thoracic Medicine
- 邱政廸 Division of Neurology
- Fu-Yu Lin Division of Neurology
- 李英玄 Division of Radiology
- 賴怡君 Division of Psychiatry
- 邱正廸 Division of Neurology
- 王宇澄 Division of Cardiovascular Diseases
- Wei-Chung Wang Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
41 participants
-
Global
41 participants
